Glycosylated Ferritin in Macrophagic Activation Syndromes

Clinical trial NCT02143986 · RECRUITING

Trial details

NCT number: NCT02143986
Sponsor: Brugmann University Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Still's Disease, Adult-Onset Sepsis Macrophagic Activation Syndrome

Start date: 2014-05-01
Primary completion: 2030-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.